Abstract:A pore-forming protein (PFP/perforin/cytolysin), stored in the cytoplasmic granules of cytolytic lymphocytes, lyses a variety of target cells but not the cytolytic lymphocytes. In the complement (C) system, a C8-binding protein (C8bp) or homologous restriction factor (HRF) has been described that protects cells against lysis mediated by homologous C. C8bp/HRF is known to bind to C8 and C9 and has also been suggested to protect lymphocytes against perforin-mediated lysis. Here, using an anti-idiotypic antibody approach, several polyclonal antisera were raised against IgGs that are specific for mouse perforin, and human C8 and C9. These anti-idiotypic antisera were shown to react against an overlapping epitope(s) on C8bp/HRF as indicated by the following evidence: (i) all three types of antisera reacted against partially purified C8bp/HRF and against a 65 kDa protein band in cell lysates; reactivity was only observed against disulfide-reduced antigens; (ii) the three antibodies react with a protein band in normal erythrocytes (E) but not with type III E of patients with paroxysmal nocturnal hemoglobinuria or with a mutant B lymphoblastoid cell line, both of which cell types are known to be deficient in C8bp/HRF; and (iii) the three antibodies compete with each other for binding to C8bp/HRF. Type III E and the C8bp/HRF-deficient mutant lymphoblastoid cell line, however, are as susceptible to perforin-mediated lysis as type I E and wild-type lymphoblastoid cell line, respectively, indicating that C8bp/HRF does not play a role in protecting cells against perforin-mediated lysis. These paradoxical findings suggest that perforin may share with C8 and C9 the same domain(s) that bind to C8bp/HRF and yet, unlike C8 and C9, perforin is not inactivated by this type of putative interaction. Since C8 and C9 are now readily available, the anti-idiotypic approach described here provides a convenient protocol for production of antisera specific for C8bp/HRF.

Plasma membrane-associated proteins with the ability to partially inhibit perforin-mediated lysis

Cytoplasts from Cytotoxic T Lymphocytes Are Resistant to Perforin-Mediated Lysis.

Resistance Of Cytolytic Lymphocytes To Perforin-Mediated Killing - Murine Cyto-Toxic Lymphocytes-T And Human Natural-Killer Cells Do Not Contain Functional Soluble Homologous Restriction Factor Or Other Specific Soluble Protective Factors

Resistance Of Cytolytic Lymphocytes To Perforin-Mediated Killing - Induction Of Resistance Correlates With Increase In Cyto-Toxicity

Perforin binding to cells and lipid membranes determined by a simple competition assay

Perforin is Recaptured by Natural Killer Cells Following Target Cells Stimulation for Cytotoxicity.

TO PERFORIN-MEDIATED KILLING Induction of Resistance Correlates with Increase in Cytotoxicity

Resistance to the Pore-Forming Protein of Cytotoxic T Cells: Comparison of Target Cell Membrane Rigidity.

The killing effects of human perforin on various tumor cells

Purification of a membrane-associated serine esterase from murine cytotoxic T lymphocytes by a single reverse-phase column

Anti-idiotypic Antibodies Derived Against C8, C9 and Perforin Bind Homologous Restriction Factor

The lymphocyte pore-forming protein perforin is associated with granules by a pH-dependent mechanism

Perforin and granzymes: function, dysfunction and human pathology

Full-length Cloning and 3′-Terminal Portion Expression of Human Perforin Cdna

Structural basis of Toxoplasma gondii perforin-like protein 1 membrane interaction and activity during egress

[Perforin and Granzyme--the Perfect Material of Biologic Missile].

DNA methylation and chromatin structure regulate T cell perforin gene expression.

Identification And Characterization Of A Membrane-Bound Cyto-Toxin Of Murine Cytolytic Lymphocytes That Is Related To Tumor Necrosis Factor Cachectin

Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity

Expression and bioactivity of recombinant segments of human perforin.

Expression and Bioactivity of Recombinant Segments of Human Perforinthis Paper is One of a Selection of Papers in This Special Issue, Entitled International Symposium on Recent Advances in Molecular, Clinical, and Social Medicine, and Has Undergone the Journal's Usual Peer-Review Process.